Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Rheumatology and Therapy
|
October 19, 2023
A Model to Predict Future Biologic or Targeted Synthetic DMARD Switch at a Subsequent Clinic Visit in Rheumatoid Arthritis
Laura C Cappelli, George Reed, Dimitrios A Pappas, et al.
ACR Open Rheumatology
|
December 7, 2023
Anti-Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis
Laura C Cappelli, David Hines, Hong Wang, et al.
Arthritis Care & Research
|
December 21, 2016
Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature
Laura C Cappelli, Anna Kristina Gutierrez, Clifton O Bingham, et al.
Rheumatic Diseases Clinics of North America
|
April 26, 2024
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management
Namrata Singh, Anupama Shahane, Jeffrey A Sparks, et al.
Rheumatology (Oxford, England)
|
August 30, 2023
Baseline predictors of disease severity in immune checkpoint inhibitor-induced inflammatory arthritis
Laura C Cappelli, Omer Kamal, Michelle Jones, et al.
RMD Open
|
June 7, 2019
Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
Cassandra Calabrese, Laura C Cappelli, Marie Kostine, et al.
Arthritis Research & Therapy
|
March 24, 2018
Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
Laura C Cappelli, Maximilian F Konig, Allan C Gelber, et al.
Immunological Reviews
|
January 14, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis
Laura C Cappelli, Mekha A Thomas, Clifton O Bingham, et al.
Rheumatology (Oxford, England)
|
December 4, 2018
Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis
Laura C Cappelli, Mehmet T Dorak, Maria P Bettinotti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 4, 2018
Association of Baseline Peptidylarginine Deiminase 4 Autoantibodies With Favorable Response to Treatment Escalation in Rheumatoid Arthritis
Erika Darrah, Fang Yu, Laura C Cappelli, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Rheumatology and Therapy
|
October 19, 2023
A Model to Predict Future Biologic or Targeted Synthetic DMARD Switch at a Subsequent Clinic Visit in Rheumatoid Arthritis
Laura C Cappelli, George Reed, Dimitrios A Pappas, et al.
ACR Open Rheumatology
|
December 7, 2023
Anti-Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis
Laura C Cappelli, David Hines, Hong Wang, et al.
Arthritis Care & Research
|
December 21, 2016
Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature
Laura C Cappelli, Anna Kristina Gutierrez, Clifton O Bingham, et al.
Rheumatic Diseases Clinics of North America
|
April 26, 2024
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management
Namrata Singh, Anupama Shahane, Jeffrey A Sparks, et al.
Rheumatology (Oxford, England)
|
August 30, 2023
Baseline predictors of disease severity in immune checkpoint inhibitor-induced inflammatory arthritis
Laura C Cappelli, Omer Kamal, Michelle Jones, et al.
RMD Open
|
June 7, 2019
Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
Cassandra Calabrese, Laura C Cappelli, Marie Kostine, et al.
Arthritis Research & Therapy
|
March 24, 2018
Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
Laura C Cappelli, Maximilian F Konig, Allan C Gelber, et al.
Immunological Reviews
|
January 14, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis
Laura C Cappelli, Mekha A Thomas, Clifton O Bingham, et al.
Rheumatology (Oxford, England)
|
December 4, 2018
Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis
Laura C Cappelli, Mehmet T Dorak, Maria P Bettinotti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 4, 2018
Association of Baseline Peptidylarginine Deiminase 4 Autoantibodies With Favorable Response to Treatment Escalation in Rheumatoid Arthritis
Erika Darrah, Fang Yu, Laura C Cappelli, et al.
Page
of 6